ea0047oc14 | Spotlight on Neuroendocrine tumours | Theranostics2016
Lassmann Michael
, Werner Rudolf A.
, Weich Alexander
, Wester Hans-Juergen
, Scheurlen Michael
, Higuchi Takahiro
, Samnick Samuel
, Bluemel Christina
, Rudelius Martina
, Buck Andreas K.
, Lapa Constantin
, Herrmann Ken
Introduction: Diagnostic imaging of neuroendocrine tumors (NETs) is the domain of somatostatin receptor (SSTR) agonists as well as FDG PET/CT in dedifferentiated tumors. SSTR also serves as target for receptor directed peptide therapy. More recently, specific ligands targeting the chemokine receptor 4 (CXCR4) were introduced potentially offering an additional theranostic option in NETs. Here we evaluated the CXCR4 expression using 68Ga-Pentixafor PET/CT in NET patie...